The JSE was weaker on Tuesday, while its global counterparts were mixed as investors digest the news of the development of a coronavirus vaccine.

On Monday, drugmakers Pfizer and BioNTech announced that the preliminary results of their vaccine show it prevents more than 90% of infections, giving hope that there may be a return to economic normality in the coming months...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.